There has never been a documented malicious attack on someone's implantable cardiac defibrillator." A spokesperson from Medtronic said that the devices, which had carried such telemetry for 30 ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

As a technical fellow for Medtronic, Yanina Grinberg works on pacemakers and implantable cardiac defibrillators. A 16-year veteran of the medtech giant, she drives innovation and impact at ...

Medtronic plc (NYSE ... Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable ...

Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps ...

Medtronic plc (NYSE:MDT – Get Free Report) has received a consensus rating of “Hold” from the sixteen ratings firms that are ...

The global defibrillator market was valued at US$ 7.2 billion in 2021 and is estimated to expand at a compound annual growth ...

A pair of artificial intelligence algorithms from Boston Scientific and Medtronic ... of worsening heart failure in people with CIEDs – pacemakers, implantable cardioverter defibrillators ...

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves ...